Dreavent is a Boston-based biotech venture capital firm with a structured model to connect scientific ecosystems to Boston's biotech infrastructure, engineering assets against confirmed pharmaceutical interest. Our Bio Asset Engineering Platform combines a specialized Linking Team embedded in both the local ecosystem and Boston, a Boston Development Platform where assets are developed to global pharmaceutical standards, and the Dreavent Engine, a proprietary AI-powered investment intelligence system. Spain is the first implementation. The model is designed to scale globally, with Boston as the permanent hub.  
Dreavent. Connecting Ecosystems.

Dreavent

Org chart

Teams

Offices